Filing Details

Accession Number:
0001209191-19-033233
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-29 17:00:13
Reporting Period:
2019-05-24
Accepted Time:
2019-05-29 17:00:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
831547 Spectrum Pharmaceuticals Inc SPPI Pharmaceutical Preparations (2834) 930979187
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311636 Mitchell Stuart Krassner 11500 S. Eastern Avenue
Suite 240
Henderson NV 89052
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2019-05-24 5,071 $6.09 73,015 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2019-05-24 5,071 $7.94 67,944 No 4 S Direct
Common Stock, $0.001 Par Value Acquisiton 2019-05-28 44,929 $6.09 112,873 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2019-05-28 37,385 $8.00 75,488 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Exercise (Right to Buy) Disposition 2019-05-24 5,071 $0.00 5,071 $6.09
Common Stock Stock Option Exercise (Right to Buy) Disposition 2019-05-28 44,929 $0.00 44,929 $6.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
44,929 2012-06-26 2019-06-26 No 4 M Direct
0 2012-06-26 2019-06-26 No 4 M Direct
Footnotes
  1. This transaction represents an open market sale of a portion of the expiring stock options exercised on this Form 4 to satisfy the Reporting Person's payment of the exercise price and the taxes associated with such exercise.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.94 to $7.965, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.995 to $8.01, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.